Pathologically, ALS/MND is characterized by motor neuron and pyramidal tract degeneration, together with various proteinaceous inclusions composed principally of TDP‐43 (MND‐TDP) or cystatin C. This evidence concerns the gene CST3 and mild neurocognitive disorder.